Your session is about to expire
← Back to Search
Opiate Sparing Protocol for Wrist Fractures
Study Summary
This trial looks at whether using less opiate medication results in less pain for people who have just had surgery to fix a broken bone in their wrist.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2013 Phase 3 trial • 653 Patients • NCT00316277Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have chronic pain that lasts a long time.I have an injury or condition in the same arm, but not including the wrist.I had surgery to fix broken bones at Campbell Clinic.I have a history of kidney disease.I take medication for high blood pressure.
- Group 1: Opiate Sparing
- Group 2: Opiate Based
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any open opportunities for individuals to join this clinical examination?
"This investigation, as displayed on clinicaltrials.gov, is not presently enrolling patients; the trial was first posted on March 1st 2022 and last edited June 28th 2022. Despite this study no longer recruiting, 353 other medical experiments are currently seeking participants to take part in their research."
Am I eligible to join the experiment?
"In order to take part in this clinical trial, applicants must have sustained a fracture and be between 18-85 years of age. A total of 72 patients will ultimately join the research."
Is the recruitment process inclusive of individuals aged 45 and over?
"This clinical trial is accepting applicants who are aged 18 and above, but no older than 85."
Share this study with friends
Copy Link
Messenger